COMPLIVISE
All products
06QPPV Oversight

COMPLIVISE Oversight

One view of the pharmacovigilance system for the QPPV.

Launch app

QPPV compliance view — current period

PV system · 14 markets · period 01–13 Aug

  • Expedited reporting — 15-day cases

    212 of 214 submitted within timeline

    Deviation — rationale required

    2 deviations under review

  • Vendor delivery — regional case processing

    Quality review sampling at agreed rate

    Within agreement

    Vendor N. Partner · Q3 review

  • PSMF annex currency

    Two annexes pending update after vendor change

    Update in progress

    A. Kulkarni · due 30 Aug

Every metric retains its source, period and the QPPV decision recorded against it. · Illustrative product experience.

How the work moves, end to end.

What enters
Case-processing status, literature surveillance, aggregate-reporting timelines, signal status, vendor delivery, safety-agreement obligations and regulatory commitments.
What is assessed
Compliance-metric evaluation against agreed timelines, deviation detection, vendor-performance review and inspection-readiness scoring.
What action follows
Escalation to accountable owners, CAPA initiation, obligation follow-up and preparation of the PV system master file evidence pack.
What evidence remains
Metric source, calculation period, deviation rationale, escalation record and QPPV sign-off with timestamp.

What it does.

  • PV-system performance
  • ICSR-processing visibility
  • Literature-surveillance oversight
  • Aggregate-reporting status
  • Signal-management status
  • Vendor performance
  • Safety-agreement obligations
  • Regulatory commitments
  • PSMF supporting evidence
  • Inspection readiness
  • Compliance dashboards
  • QPPV sign-off records

Next layer

COMPLIVISE Literature

From literature search to validated ICSR.

Explore Literature Intelligence